4212
Helvetica Chimica Acta Vol. 86 (2003)
HÀC(5,5')); 8.29 (d, 4 H, HÀC(6,6'), HÀC(3,3')(bpy)); 8.11 (d, 4J 1.8, 2 H, HÀC(9,9')); 7.91 (t, 3J 8.2, 2 H,
HÀC(4,4')(bpy)); 7.32 (m, 6 H, 4 Ho, HÀC(2,2')); 7.24 (d, 3J 7.0, 2 H, HÀC(5,5')(bpy)); 7.11 (d, 3J 8.8,
4 Hm); 6.94 (m, 4 H, HÀC(3,3'), HÀC(c')); 6.50 (d, 3J 7.7, 2 H, H ÀC(c)); 5.85 (m, 2 Hr); 5.3 5.0 (m, 4 H,
Hs,t); 4.5 (m, 2 H, Ha or Ha1); 4.25 (m, 2 H, Ha or Ha1); 3.96 (m, 6 H, Hq, Hb'); 3.7 3 (m, 54 H, Hb,g,d,e, Hg,h,i,j,k,l,n,p
,
H
a',b,a); 2.5 (m, 4 Hf); 1.3 (m, 6 H, Hd or Hd', He); 1.0 (m, 2 H, Hd or Hd'). FAB-MS: 1827.7 ([23(PF6)] ; calc.
1827.7), 1682.7 ([23]; calc. 1682.7), 841.3 ([23]2; calc. 841.3).
[6,6'-Bis(4,7,10,13,16-pentaoxanonadec-18-en-1-yl)-2,2'-bipyridine-kN1,kN1']{15,16,18,19,21,22,34,35,37,38,
40,41,56,57,62,63-hexadecahydro-28,28-dimethyl-10,13:24,27:29,32:43,46:58,61-pentaetheno-9,4,7:47,49,52-bis-
(methenonitrilomethyno)-28H-[1,4,7,10,20,23,26,29]octaoxacyclononapentacontino[39,40-c:50,49-c']dipyridine-
kN3,kN53,kN67,kN78}ruthenium(2) Bis[hexafluorophosphate(1 À )] ([24](PF6)2). Asdescribed for [ 23](PF6)2,
with [16]/(PF6)2 (25 mg, 1.5 ¥ 10À5 mol), 22 (17 mg, 2.4 ¥ 10À5 mol), ethylene glycol (3 ml), and aq. sat.K(PF6)
soln. (8 ml): [24](PF6)2 (16 mg, 46%). Orange solid. 1H-NMR (300 MHz, CD3CN)2): 8.88 (d, 4J 1.4, 2 H,
HÀC(7,7')); 8.43 8.29 (d and s, 3J 9.2, 6 H, HÀC(5,5'), HÀC(6,6'), HÀC(9,9')); 7.86 (d, 3J 7.86, 2 H,
HÀC(3,3')(bpy)); 7.86 (t, 4J 7.86, 2 H, HÀC(4,4')(bpy)); 7.59 (d, 3J 8.8, 4 Ho); 7.21 (m, 3J 8, 2 H,
HÀC(5,5')(bpy)); 7.16 (d, 3J 8.07, 4 Hm); 7.11 7.07 (2d, 3J 8.7, 6 H, 4 Ho', HÀC(2,2')); 6.94 (d, 3J 5.6,
2 H, HÀC(3,3')); 6.8 (d, 3J 8.7, 6 H, 4 Hm', HÀC(c')); 6.39 (d, 3J 7.8, 2 H, HÀC(c)); 5.9 (m, 2 Hr); 5.3 5.0
(m, 4 H, Hs,t); 4.3 (m, 2 H, Ha or Ha1); 4.25 (m, 2 H, Ha or Ha1); 3.96 (m, 6 H, Hq, Hb'); 3.7 3.0 (m, 58 H,
H
b,g,d,e,l, Hg,h,i,j,k,l,n,p, Ha,a',b); 2.5 (m, 4 Hf); 1.45 (s, 2 Me); 1.3 (m, 6 H, Hd or Hd', He); 1.2 (m, 2 H, Hd or Hd'). ES-
MS: 2081.9 ([24(PF6)] ; calc. 2082.1), 968.5 ([24]2; calc. 968.5).
[24Z)-10,13,16,19,22,27,30,33,36,39-Decaoxa-47,48-diazatricyclo[41.3.1.12,6]octatetraconta-1(47),2,4,6(48),
24,43,45-heptaene-kN47,kN48]{15,16,18,19,21,22,24,25,27,28,43,44,49,50-tetradecahydro-10,13:30,33:45,48-triethe-
no-9,4,7:34,36,39-bis(methenonitrilomethyno)[1,4,7,10,13,16](hexaoxacyclohexatetracontino[26,27-c:37,36-c']di-
pyridine-kN3,kN40,kN54,kN61}ruthenium(2) Bis[hexafluorophosphate(1 À )] ([25](PF6)2). Complex
[23](PF6)2, (29 mg, 1.5 ¥ 10À5 mol) and [Ru(CHPh)]Cl2(PCy3)2] (1 mg) were dissolved in freshly distilled
CH2Cl2 to yield a 0.01m soln. which was stirred at r.t. for several days. Each two days the reaction was stopped,
the mixture analyzed by 1H-NMR, and more ruthenium catalyst added. After one week, a total of 6 mg of the
Grubbs catalyst was added, and the reaction was finished. The mixture was submitted to CC (silica gel, MeCN/
H2O/sat. aq. KNO3 soln. 100 :10 :2) and then to anion exchange: [25](PF6)2 (20 mg, 68%). Orange crystalline
solid. UV/VIS (MeCN): 341 (4.39), 455 (3.99). 1H-NMR (500 MHz, CD3CN)2): 8.84 (d, 4J 1.8, 2 H,
HÀC(7,7')); 8.41 (d, 3J 9.1, 2 H, HÀC(5,5')); 8.31 (d, 3J 9.1, 2 H, HÀC(6,6')); 8.27 (d, 3J 8.0, 2 H,
HÀC(3,3')(bpy)); 8.13 (d, 4J 1.8, 2 H, HÀC(9,9')); 7.91 (dd, 3J 8.0, 2 H, HÀC(4,4')(bpy)); 7.34 (d, 3J 8.8,
4 Ho); 7.32 (d, 3J 5.6, 2 H, HÀC(2,2')); 7.24 (d, 3J 7.0, 2 H, HÀC(5,5')(bpy)); 7.12 (d, 3J 8.8, 4 Hm); 6.96
(d, 3J 5.6, 2 H, HÀC(3,3')); 6.94 (d, 3J 9.9, 2 H, HÀC(c')); 6.51 (d, 3J 9.9, 2 H, HÀC(c)); 5.78 (m, Hr, 88%
cis); 5.63 (m, Hr, 12% trans); 4.5 (m, 2 H, Ha or Ha1); 4.2 (m, 2 H, Ha or Ha1); 3.96 (m, 6 H, Hq and Hb'); 3.7 3.0
(m, 54 H, Hb,g,d,e, Hg,h,i,j,k,l,n,p, Hb,a,a'); 2.5 (m, 4 Hf); 1.3 (m, 6 H, Hd or Hd', and He); 1.0 (m, Hd or Hd'). 2D-ROESY
NMR. ES-MS: 1799.7 ([25](PF6)] ; calc. 1799.7), 827.4 ([25]2; calc. 827.8).
[(24Z)-10,13,16,19,22,27,30,33,36,39-Decaoxa-47,48-diazatricyclo[41,3.1.12,6]octatetraconta-1(47),2,4,6,(48),
24,43,45-heptaene-kN47,kN48]{15,16,18,19,21,22,34,35,37,38,40,41,56,57,62,63-hexadecahydro-28,28-dimethyl-
10,13:24,27:29,32:43,46:58,61-pentaetheno-9,4,7:47,49,52-bis(methenonitrilomethyno)-28H-[1,4,7,10,20,23,26,29]-
octaoxacyclononapentacontino[39,40-c:50,49-c']dipyridine-kN3,kN53,kN67,kN78}ruthenium(2) Bis[hexa-
fluorophosphate(1 À )] ([26](PF6)2). Complex [24](PF6)2, (16 mg, 7.2 ¥ 10À6 mol) and [Ru(CHPh)Cl2(PCy3)2
]
(1.2 mg, 20 mol-%) were dissolved at r.t. in freshly distilled CH2Cl2 to yield a 0.1m soln. which was stirred for
several days. After one day, the reaction was stopped, and more catalyst was added (2 mg). After three days, a
total of 4 mg of the Grubbs catalyst was added, and the reaction was finished. The mixture was submitted to CC
(silica gel, MeCN/H2O/sat. aq. KNO3 soln. 100 :7:1) and then to anion exchange [26](PF6)2 (12 mg, 76%).
Orange crystalline solid. UV/VIS (MeCN): 460 (4.1). 1H-NMR (400 MHz, CD3CN): 8.88 (d, 4J 1.7, 2 H,
HÀC(7,7')); 8.40 8.29 (d, 3J 9.2, 6 H, HÀC(5,5'), HÀC(6,6'), HÀC(9,9')); 8.12 (d, 3J 7.7, 2 H,
HÀC(3,3')(bpy)); 7.73 (t, 3J 7.7, 2 H, H ÀC(4,4')); 7.56 (d, 3J 8.7, 4 Ho); 7.15 (d, 3J 7.7, 2 H,
HÀC(5,5')(bpy)); 7.13 (d, 3J 8.8, 4 Hm); 7.07 7.0 (2d, 3J 8.8, 3J 5.4, 6 H, HÀC(2,2'), 4 Ho'); 7.99 (d, 3J
5.4, 2 H, HÀC(3,3')); 7.12 (2d, 3J 8.8, 6 H, 4 Hm', 2 HÀC(c')); 6.36 (d, 3J 9.2, 2 H, HÀC(c)); 5.78 (m, Hr);
4.25 (m, 4 Ha); 4.00 (m, 8 H, Hl, Hq); 3.79 (m, 4 Hb); 3.7 3 (m, 32 H, Hg,d,e, Hj,k,l,n,p); 3.47 (m, 4 Hi); 3.28
(m, 4 Hh); 3.05 (m, 4 Hg); 4.0-3.0 (m, 8 H, Ha,a',b,b'); 2.5 (m, 4 Hf); 1.3 (m, 6 H, Hd or Hd', He); 1.40 (s, 2 Me); 1.2
(m, 2 H, Hd or Hd'). 2D-ROESY NMR. ES-MS: 2053.7 ([26](PF6)] , calc. 2053.1), 954.4 ([26]2; calc. 954.05).